|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0500 - 0.0512|
|52 Week Range||0.0250 - 0.1998|
|Beta (5Y Monthly)||0.87|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jan 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sproutly Canada, Inc. (CSE:SPR) (OTCQB:SRUTF) (FSE:38G) ("Sproutly" or the "Company"), is pleased to announce it has executed the definitive agreement (the "Agreement") with CannaHive Inc. ("CannaHive"), consistent with the revised letter of intent that was announced in February of this year. This agreement finalizes the commercial arrangement with CannaHive to produce Cannabis 2.0 products at the Company’s subsidiary, Toronto Herbal Remedies’ ("THR"), licensed facility.
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company") is pleased to announce that, further to its news release dated March 15, 2021, it has closed the second and final tranche of its financing. Under the final tranche of the private placement, the Company issued 15,916,037 units of the Company (the "Units") at a price of $0.05 per Unit for gross proceeds of approximately $795,802, with each Unit consisting of one common share and one non-transferable common share purchase warrant. Each warrant entitles the holder to acquire an additional common share at an exercise price of $0.07 for a period of two years from the date of issue.